Carboplatin recalls
The FDA has published 6 recalls involving Carboplatin since 2012. The latest was reported on 26 Aug 2015. Most were for particulate matter. Hospira has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls6since 2012
Last 12 months0reported
Class I350% of total
Ongoing0latest 26 Aug 2015
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 3 50%Class II 2 33%Class III 1 17%
Why carboplatin is recalled
Companies
By year
All carboplatin recalls, newest first
6 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | CARBOplatin Injection 450 mg/ (10 mg/mL) recalled by Mylan Institutional | Mylan Institutional | Particulate Matter | Nationwide |
| Drug | CLASS II | CARBOplatin Injection, 600 mg/, MultiDose recalled | Teva Pharmaceuticals USA | Sterility | Nationwide |
| Drug | CLASS I | Carboplatin Injection, 600 mg/ (10 mg/mL), Cytotoxic Agent recalledCarboplatin | Hospira | Particulate Matter | Nationwide |
| Drug | CLASS I | Carboplatin Injection, 450 mg/ (10 mg/mL), Cytotoxic Agent recalledCarboplatin | Hospira | Particulate Matter | Nationwide |
| Drug | CLASS II | Carboplatin Injection, 10 mg/mL Multi-Dose Vial recalled by HospiraCarboplatin | Hospira | Particulate Matter | Nationwide |
| Drug | CLASS III | Carboplatin Injection, 10 mg/mL, a) multi-dose vials recalled by HospiraCarboplatin | Hospira | Potency & Assay | Nationwide |
Should you stop taking Carboplatin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.